Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from C.E.Management Integrated Laboratory Co., Ltd. ( (JP:6171) ) is now available.
C.E.Management Integrated Laboratory Co., Ltd. reported a slight increase in its financial performance for the nine months ending September 30, 2025, with net sales rising by 2.5% and operating profit increasing by 5.8% compared to the previous year. The company’s financial position remains stable with a high equity ratio, and it forecasts continued growth in net sales and profits for the full year 2025, indicating a positive outlook for stakeholders.
The most recent analyst rating on (JP:6171) stock is a Buy with a Yen506.00 price target. To see the full list of analyst forecasts on C.E.Management Integrated Laboratory Co., Ltd. stock, see the JP:6171 Stock Forecast page.
More about C.E.Management Integrated Laboratory Co., Ltd.
C.E.Management Integrated Laboratory Co., Ltd. operates in the laboratory industry, focusing on providing integrated management services. The company is listed on the Tokyo Stock Exchange and is known for its strategic IP business division.
Average Trading Volume: 234,303
Technical Sentiment Signal: Buy
Current Market Cap: Yen6.45B
For detailed information about 6171 stock, go to TipRanks’ Stock Analysis page.